Longitudinal Phenotypes of Type 1 Diabetes in Youth Based on Weight and Glycemia and Their Association With Complications
Overview
Authors
Affiliations
Context: Subclinical and clinical complications emerge early in type 1 diabetes (T1D) and may be associated with obesity and hyperglycemia.
Objective: Test how longitudinal "weight-glycemia" phenotypes increase susceptibility to different patterns of early/subclinical complications among youth with T1D.
Design: SEARCH for Diabetes in Youth observational study.
Setting: Population-based cohort.
Participants: Youth with T1D (n = 570) diagnosed 2002 to 2006 or 2008.
Main Outcome Measures: Participants were clustered based on longitudinal body mass index z score and HbA1c from a baseline visit and 5+ year follow-up visit (mean diabetes duration: 1.4 ± 0.4 years and 8.2 ± 1.9 years, respectively). Logistic regression modeling tested cluster associations with seven early/subclinical diabetes complications at follow-up, adjusting for sex, race/ethnicity, age, and duration.
Results: Four longitudinal weight-glycemia clusters were identified: The Referent Cluster (n = 195, 34.3%), the Hyperglycemia Only Cluster (n = 53, 9.3%), the Elevated Weight Only Cluster (n = 206, 36.1%), and the Elevated Weight With Increasing Hyperglycemia (EWH) Cluster (n = 115, 20.2%). Compared with the Referent Cluster, the Hyperglycemia Only Cluster had elevated odds of dyslipidemia [adjusted odds ratio (aOR) 2.22, 95% CI: 1.15 to 4.29], retinopathy (aOR 9.98, 95% CI: 2.49 to 40.0), and diabetic kidney disease (DKD) (aOR 4.16, 95% CI: 1.37 to 12.62). The EWH Cluster had elevated odds of hypertension (aOR 2.18, 95% CI: 1.19 to 4.00), dyslipidemia (aOR 2.36, 95% CI: 1.41 to 3.95), arterial stiffness (aOR 2.46, 95% CI: 1.09 to 5.53), retinopathy (aOR 5.11, 95% CI: 1.34 to 19.46), and DKD (aOR 3.43, 95% CI: 1.29 to 9.11).
Conclusions: Weight-glycemia phenotypes show different patterns of complications, particularly markers of subclinical macrovascular disease, even in the first decade of T1D.
Major adverse events in youth-onset type 1 and type 2 diabetes: The SEARCH and TODAY studies.
Mottl A, Tryggestad J, Isom S, Gubitosi-Klug R, Henkin L, White N Diabetes Res Clin Pract. 2024; 210:111606.
PMID: 38493952 PMC: 11103672. DOI: 10.1016/j.diabres.2024.111606.
Postprandial Glucose Variability Following Typical Meals in Youth Living with Type 1 Diabetes.
Patton S, Bergford S, Sherr J, Gal R, Calhoun P, Clements M Nutrients. 2024; 16(1).
PMID: 38201991 PMC: 10781146. DOI: 10.3390/nu16010162.
Pucchio A, Krance S, Pur D, Bhatti J, Bassi A, Manichavagan K Graefes Arch Clin Exp Ophthalmol. 2023; 262(4):1041-1091.
PMID: 37421481 DOI: 10.1007/s00417-023-06100-6.
OSullivan S, Schmaal L, DAlfonso S, Toenders Y, Valentine L, McEnery C JMIR Ment Health. 2022; 9(4):e29211.
PMID: 35389351 PMC: 9030973. DOI: 10.2196/29211.
Kahkoska A, Pokaprakarn T, Alexander G, Crume T, Dabelea D, Divers J Diabetes Care. 2021; 45(1):108-118.
PMID: 34728528 PMC: 8753766. DOI: 10.2337/dc21-0496.